- This blog is a discussion about our system of public and private health care.
-

Blogroll
About Me
Alison Bass is a Pulitzer Prize nominee and author of Side Effects: A Prosecutor, a Whistleblower and a Bestselling Antidepressant on Trial, which won the NASW Science in Society Award. She was a longtime medical and science writer for The Boston Globe and has also written for The Miami Herald, Psychology Today and MIT's Technology Review, among other publications. A series she wrote for The Boston Globe on psychiatry was nominated for a Pulitzer Prize and she has received many other journalism awards. In 2007, she won a prestigious Alicia Patterson Fellowship to write Side Effects. Bass teaches journalism at Mount Holyoke College and Brandeis University.Blog Archive
- June 2013 (1)
- February 2013 (1)
- November 2012 (1)
- October 2012 (1)
- September 2012 (4)
- August 2012 (1)
- July 2012 (2)
- June 2012 (3)
- May 2012 (3)
- April 2012 (2)
- February 2012 (2)
- January 2012 (3)
- December 2011 (3)
- November 2011 (3)
- October 2011 (2)
- September 2011 (4)
- August 2011 (3)
- July 2011 (3)
- June 2011 (4)
- May 2011 (4)
- April 2011 (3)
- March 2011 (3)
- February 2011 (3)
- January 2011 (4)
- December 2010 (3)
- November 2010 (2)
- September 2010 (2)
- July 2010 (1)
- May 2010 (1)
- April 2010 (1)
- March 2010 (3)
- February 2010 (3)
- January 2010 (4)
- December 2009 (4)
- November 2009 (5)
- October 2009 (4)
- September 2009 (6)
- August 2009 (7)
- July 2009 (4)
- June 2009 (5)
- May 2009 (4)
- April 2009 (7)
- March 2009 (4)
- February 2009 (3)
- January 2009 (4)
- December 2008 (4)
- November 2008 (3)
- October 2008 (4)
- September 2008 (5)
- August 2008 (2)
- July 2008 (6)
- June 2008 (5)
- May 2008 (1)
- April 2008 (1)
Monthly Archives: May 2009
Why our health care costs are so high and what we can do about it
Share In order to truly stabilize the economy and rescue Medicare from financial collapse, the Obama administration knows it has to do something about the elephant in the room: ever-rising health care costs. In this week’s New Yorker, surgeon-writer Atul … Continue reading
Posted in Uncategorized
4 Comments
Denis Maltez is the reason we need to know who is shilling for Big Pharma
Share On his Pharma Marketing blog today, John Mack recaps the controversy over the patient who was paid hundreds of thousands of dollars by Bristol Myers Squibb to promote Abilify and then changed his tune. (Andy Behrman, aka “Electroboy,” began … Continue reading
Posted in Uncategorized
1 Comment
Senior citizens wising up to Big Pharma
Share I had the pleasure of speaking to a large group of senior citizens yesterday at a Jewish community center in the Boston area. I had been invited there to talk about Side Effects, and while the focus of my … Continue reading
Posted in Uncategorized
2 Comments
The media storm over swine flu: one more reason why good health journalism matters
Share As The Boston Globe‘s unions vote on whether to bow to the inevitable and make the financial concessions demanded to keep their newspaper alive, it seems a sad but apropos time to bring attention to a new survey on … Continue reading
Posted in Uncategorized
1 Comment